Alzheimer's Association Welcomes FDA Approval of First Non-Antipsychotic Treatment for Alzheimer's Disease Agitation
May 05, 2026
May 05, 2026
CHICAGO, Illinois, May 5 [Category: Health Care] -- The Alzheimer's Association posted the following news release:
* * *
Alzheimer's Association Welcomes FDA Approval of First Non-Antipsychotic Treatment for Alzheimer's Disease Agitation
*
The Alzheimer's Association welcomes today's U.S. Food and Drug Administration (FDA) approval of Auvelity(r) (AXS-05, dextromethorphan-bupropion, Axsome Therapeutics) for the treatmen . . .
* * *
Alzheimer's Association Welcomes FDA Approval of First Non-Antipsychotic Treatment for Alzheimer's Disease Agitation
*
The Alzheimer's Association welcomes today's U.S. Food and Drug Administration (FDA) approval of Auvelity(r) (AXS-05, dextromethorphan-bupropion, Axsome Therapeutics) for the treatmen . . .